Exhibit 99.1 Fifth Consecutive Quarter of Positive Net Income and EBITDA , Gross Margin increased to 4.4% BURLESON, Texas, August 14, 2025 (ACCESSWIRE) - Sadot Group Inc. (Nasdaq: SDOT) ("Sadot Group", "Sadot" or the "Company"), an emerging player in the global food supply chain sector, today announced its financial results for the second quarter ended June 30, 2025. Chief Executive Officer, Haggai Ravid and Chief Financial Officer, Paul Sansom will host a conference call at 11:00am EDT / 8:00am PDT on Augu ...

News Summary Exhibit 99.1 Sandisk Reports Fiscal Fourth Quarter 2025 Financial Results MILPITAS, Calif. — August 14, 2025 — Sandisk Corporation (Nasdaq: SNDK) today reported fiscal fourth quarter financial results. "Sandisk delivered strong results this quarter, with revenue and non-GAAP EPS exceeding our guidance. We continue to execute with discipline, balancing innovation and operational focus," said David Goeckeler, Sandisk CEO. "The ramp of BiCS8 brings new levels of performance, density and energy eff ...

Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ~$28 million at closing and is eligible to receive up to an additional $4.8 million under a contingent value right (CVR), plus a 2.5% royalty on future net sales of UNLOXCYT™ (cosibelimab-ipdl) FDA accepted New Drug Application filing for priority review of CUTX-101 to treat Menkes disease; PDUFA goal date of September 30, 2025 E ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-36745 Applied DNA Sciences, Inc. (Exact name of registrant as specified in its charter) | Delaware | 59-2262718 | | --- | ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to ___________________ Commission File Number: 001-33035 WidePoint Corporation (Exact name of Registrant as specified in its charter) Delaware 52-2040 ...

Table of Contents OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-38114 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 AVENUE THERAPEUTICS, INC. (Exact name of registrant as specified in its charter) Delaware 47-4113275 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (State or other ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ___________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-42303 INNVENTURE, INC. (Exact name of registrant as specified in its charter) _______________________ ...

收入和利润（同比环比） - 第二季度2025年收入为750万美元，与2024年同期持平[4][5] - 第二季度2025年毛利率为43%，较2024年同期的40%上升213个基点[4][5] - 第二季度2025年净亏损为610万美元，较2024年同期的470万美元扩大[4][9] 成本和费用（同比环比） - 第二季度2025年运营费用为770万美元（不包括股权激励费用），较2024年同期的650万美元增加[8] - 第二季度2025年硬件相关成本为10万美元（包括关税和物流费用），2024年同期为0[6] - 第二季度2025年软件许可证注销费用为20万美元[6] 业务表现（合同与订单） - 截至2025年6月30日，年度合同价值(ACV)为1090万美元，同比增长11%[7] - 截至2025年6月30日，净美元收入留存率(NDRR)为131%（针对ACV超过5万美元的客户）[8] - 第二季度2025年订单额为720万美元，同比下降54%[8] 现金流状况 - 截至2025年6月30日，公司现金及现金等价物为140万美元，较2024年同期的300万美元下降[10]

Exhibit 99.1 Shimmick Corporation Announces Second Quarter 2025 Results Irvine, CA, August 14, 2025 – Shimmick Corp. (NASDAQ: SHIM), a leading infrastructure solutions provider in water, climate resilience, energy transition and sustainable transportation, today announced financial results for the second quarter ended July 4, 2025. Second Quarter 2025 and Recent Highlights "We are continuing to implement our strategic plan and starting to see its positive results as we move through 2025. We have seen increa ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 Washington 91-1663741 (State or other jurisdiction of incorporation or organization) or 201 Elliott Avenue West Seattle, Washington 98119 (Address of principal executive offices) (Zip Code) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHAN ...